Abstract 3284: Dual blockade of EGFR and TGF-Β with ficerafusp alfa has the potential to overcome resistance mechanisms in 1L R/M HNSCC in combination with pembrolizumab
Authors: Brenda C. O'Connell, Shiv R. Krishn, Pradip Nair, John Kaczmar, Christine H. Chung, Dan Zandberg, Debora J. Wong, David Raben, Rachel Salazar